Cassava Sciences, Inc.
SAVA
$2.18
$0.041.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 56.99M | 67.07M | 69.64M | 67.84M | 73.77M |
| Gross Profit | -56.99M | -67.07M | -69.64M | -67.84M | -73.77M |
| SG&A Expenses | 30.00M | 73.03M | 71.81M | 76.71M | 66.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.99M | 140.10M | 141.45M | 144.55M | 140.70M |
| Operating Income | -86.99M | -140.10M | -141.45M | -144.55M | -140.70M |
| Income Before Tax | -123.17M | -72.79M | -24.34M | -17.66M | -15.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -123.17 | -72.79 | -24.34 | -17.66 | -15.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -123.17M | -72.79M | -24.34M | -17.66M | -15.37M |
| EBIT | -86.99M | -140.10M | -141.45M | -144.55M | -140.70M |
| EBITDA | -86.03M | -139.06M | -140.31M | -143.32M | -139.34M |
| EPS Basic | -2.56 | -1.51 | -0.44 | -0.36 | -0.39 |
| Normalized Basic EPS | -1.04 | -0.87 | -0.28 | -0.36 | -0.36 |
| EPS Diluted | -2.56 | -1.51 | -1.45 | -1.38 | -1.41 |
| Normalized Diluted EPS | -1.04 | -0.87 | -0.29 | -0.37 | -0.37 |
| Average Basic Shares Outstanding | 192.65M | 190.54M | 185.28M | 179.37M | 173.39M |
| Average Diluted Shares Outstanding | 192.65M | 190.54M | 186.38M | 180.47M | 174.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |